The global absorbable sutures market was valued at approximately USD 2.9 billion in 2024 and is anticipated to grow to USD 3.9 billion by 2030, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2030. This growth is fuelled by several factors, including the rising demand for minimally invasive surgeries and advancements in suture technology. The trend towards less invasive procedures facilitates quicker recovery and fewer complications, leading to increased utilization of absorbable sutures across various medical fields such as general surgery, Orthopedics, and ophthalmology. Innovations in suture materials, which enhance tensile strength and biocompatibility, are also driving market expansion.Absorbable sutures are designed to dissolve gradually in the body, negating the need for removal. They are constructed from bioabsorbable materials such as polyglycolic acid (PGA), polylactic acid (PLA), polyglactin, and polydioxanone (PDO). These sutures offer numerous benefits, including reduced patient discomfort, lowered infection risk, and faster recovery times.
A significant factor contributing to market growth is the increasing volume of surgical procedures worldwide. The World Federation of Neurology reports that 12.0% of total neurology patients die from various conditions annually. Additionally, Medico Experts indicates that 22.6 million individuals experience neurological injuries, with 13.8 million requiring surgical intervention. The World Health Organization (WHO) projects that the number of Disability-Adjusted Life Years (DALYs) lost to neurological diseases will rise from 95 million in 2015 to 103 million by 2030 globally. This surge in neurological surgeries and the heightened demand for specially designed absorbable sutures are expected to further propel market growth.
Key Market Trends & Insights
• The North America absorbable sutures market led globally, securing 32.9% of the revenue share in 2024. According to the American Hospital Association Statistics 2024, there are approximately 6,120 operational hospitals in the U.S., conducting 40–50 million surgeries each year for conditions such as cardiovascular diseases, cancer, and trauma (NCBI, 2020).
• The Asia Pacific absorbable sutures market is experiencing rapid growth due to the increase in chronic diseases like cancer, diabetes, and cardiovascular conditions, especially in China, India, and Japan. With 1.4 million cancer diagnoses reported in India in 2022, the demand for advanced surgical tools is rising.
• By product type, the needled absorbable sterilized sutures segment held the largest revenue share at 80.9% in 2024 and is projected to grow at the fastest CAGR during the forecast period. These sutures come pre-attached to a needle, ensuring accurate and efficient application across various surgeries, including general, cardiovascular, and orthopedic procedures.
• In terms of filament type, the multifilament segment accounted for the largest revenue share of 57.0% in 2024, owing to its enhanced strength, flexibility, and ease of handling. Comprised of multiple intertwined threads, multifilament sutures offer superior knot security and are less prone to slipping during procedures.